Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot help with burning or irritation?
The O-Shot is not the first assumption for burning or irritation. It may only be discussed after assessment if symptoms appear linked with local tissue fragility, dryness, or discomfort patterns where PRP could be relevant.
Direct answer
The O-Shot is not the first assumption for burning or irritation. It may only be discussed after assessment if symptoms appear linked with local tissue fragility, dryness, or discomfort patterns where PRP could be relevant.
The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
At a glance
Clinical summary
Procedure Type
Non-surgical, autologous (using the patient's own blood) minimally invasive injection.
Mechanism of Action
Concentrated platelets release growth factors (like VEGF, EGF, PDGF) to reduce inflammation, promote revascularization, and restore vaginal mucosal.
Primary Uses for Irritation
Menopausal vaginal atrophy, vulvovaginal dryness, and Lichen Sclerosus.
Hormone-Free
It is entirely non-hormonal, making it a safe regenerative option for breast cancer survivors or those with oestrogen.
Important safety note
General Safety: Because PRP is derived from the patient's own blood (autologous), there is low but not absent risk of allergic reaction or rejection.
Suitability
Evidence
Safety
Aftercare
Detailed answer
Detailed answer
• Evidence on Burning (GSM): A 2025 prospective study comparing PRP to topical oestrogen found that patients receiving PRP showed significant improvement in Visual Analog Scale (VAS) scores for burning and dyspareunia over a 12-week period (p=0. 031). Another cohort study noted that burning sensations decreased from 51% at baseline to 15.
Clinical context
Evidence on Burning (GSM): A 2025 prospective study comparing PRP to topical oestrogen found that patients receiving PRP showed significant improvement in Visual Analog Scale (VAS) scores.
Evidence
Symptoms
Alternatives
What it means
Evidence on Burning (GSM): A 2025 prospective study comparing PRP to topical oestrogen found that patients receiving PRP showed significant improvement in Visual Analog Scale (VAS) scores.
Why it happens
Evidence on Lichen Sclerosus: Clinical studies show that PRP injections in women with biopsy-proven Lichen Sclerosus unresponsive to steroid creams resulted in over 50% achieving complete relief.
Evidence limits
Alternative to oestrogen: Literature positions PRP as a highly promising alternative for women who have failed conservative therapies or who cannot undergo systemic or topical Hormone Replacement Therapy.
Treatment fit
Suitability depends on history, symptoms, examination where appropriate and discussion of alternatives.
What this means in practice
• Treatment Setting: In-office, outpatient procedure. • Procedure Time: The entire appointment usually takes 30 to 60 minutes, with the injection itself taking less than 10 minutes. • Cost: The procedure is elective and generally not covered by insurance.
• Initial Results: While some early sensitivity changes may occur, the regenerative process takes time. Initial symptom relief (such as a decrease in burning and irritation) typically begins to emerge at around 3 to 4 weeks post-treatment.
Patient safety
Why proper assessment matters
Assessment helps separate marketing claims from safe, individualised clinical decision-making.
It checks the cause
Evidence on Burning (GSM): A 2025 prospective study comparing PRP to topical oestrogen found that patients receiving PRP showed significant improvement in Visual Analog Scale (VAS) scores.
It protects safety
General Safety: Because PRP is derived from the patient's own blood (autologous), there is low but not absent risk of allergic reaction or rejection.
It reviews alternatives
Treatment Setting: In-office, outpatient procedure.
It sets expectations
Initial Results: While some early sensitivity changes may occur, the regenerative process takes time.
A clinical decision, not a shortcut
The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.
Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.
Considerations
What to consider
• Treatment Setting: In-office, outpatient procedure. • Procedure Time: The entire appointment usually takes 30 to 60 minutes, with the injection itself taking less than 10 minutes. • Cost: The procedure is elective and generally not covered by insurance.
Consultation priorities
Step 1: Consultation: A thorough medical history review to establish candidacy, rule out infections, and discuss expectations.
Consent
Aftercare
Follow-up
Before treatment
Step 1: Consultation: A thorough medical history review to establish candidacy, rule out infections, and discuss expectations.
During care
Step 2: Blood Draw & Processing: Around 10 to 30 mL of blood is drawn from the arm and spun in a specialised centrifuge for 5 to 10.
Aftercare
Step 3: anaesthesia: A strong topical numbing cream (e.g., lidocaine/prilocaine) is applied to the vaginal walls, clitoris, and labia for about 20-30 minutes to ensure comfort.
When to reassess
Step 4: Injection: The provider uses a very fine needle to inject the PRP strategically into the anterior vaginal wall, clitoris, and any areas specifically affected by irritation.
Practical expectations
Initial Results: While some early sensitivity changes may occur, the regenerative process takes time.
Procedure Time: The entire appointment usually takes 30 to 60 minutes, with the injection itself taking less than 10 minutes.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: Burning is automatically dryness.
Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.
Myth: Irritation means PRP is the next step.
Reality: results vary, evidence may be developing, and non-response should prompt reassessment.
Myth: Treating tissue quality is enough when infection or skin disease.
Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.
Evidence and advertising
Evidence on Lichen Sclerosus: Clinical studies show that PRP injections in women with biopsy-proven Lichen Sclerosus unresponsive to steroid creams resulted in over 50% achieving complete relief.
Alternatives
Treatment Setting: In-office, outpatient procedure.
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
General Safety: Because PRP is derived from the patient's own blood (autologous), there is low but not absent risk of allergic reaction or rejection.
Are alternatives clear?
Treatment Setting: In-office, outpatient procedure.
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
General Safety: Because PRP is derived from the patient's own blood (autologous), there is low but not absent risk of allergic reaction or rejection.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
General Safety: Because PRP is derived from the patient's own blood (autologous), there is low but not absent risk of allergic reaction or rejection.
Bleeding or discharge
Common, Mild Side Effects: Patients may experience temporary mild pain, localised swelling, redness, a pinching sensation, or minor spotting/bruising at the injection site for a few days.
Infection signs
Red Flags (When to Seek Help): Severe or worsening pain, persistent or spreading redness, abnormal discharge, fever, signs of infection, or unusual loss of sensation.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Benchmark positioning
- The safest high-ranking page wins by being clinically cautious first and commercially restrained throughout.
Clinical reality
- Evidence on Burning (GSM): A 2025 prospective study comparing PRP to topical oestrogen found that patients receiving PRP showed significant improvement in Visual Analog Scale (VAS) scores for burning and dyspareunia over a 12-week.
- Evidence on Lichen Sclerosus: Clinical studies show that PRP injections in women with biopsy-proven Lichen Sclerosus unresponsive to steroid creams resulted in over 50% achieving complete relief of symptoms, and nearly 90% showing clinical.
- Alternative to oestrogen: Literature positions PRP as a highly promising alternative for women who have failed conservative therapies or who cannot undergo systemic or topical Hormone Replacement Therapy (HRT).
Timeline and expectations
- Initial Results: While some early sensitivity changes may occur, the regenerative process takes time.
- Peak Efficacy: Maximum therapeutic benefits and full tissue regeneration are usually observed between 2 to 3 months following the injections.
- Duration of Results: Results are not expected to be indefinite but generally last anywhere from 12 to 18 months (or up to 2 years for some patients).
- Treatment Frequency: Depending on the severity of the condition (e. g.
Practical logistics
- Treatment Setting: In-office, outpatient procedure.
- Procedure Time: The entire appointment usually takes 30 to 60 minutes, with the injection itself taking less than 10 minutes.
- Costs should be confirmed on the /pricing/ page before booking
- Downtime: There is virtually zero downtime. Most patients can return to normal daily activities immediately.
Research sources
- Atlihan U, et al. (2025). 'Comparison of topical oestrogen and platelet-rich plasma injections in the treatment of postmenopausal vaginal atrophy.' Frontiers in Medicine.
- Behnia-Willison F, et al. (2016). 'Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus.' Plastic and Reconstructive Surgery Global Open.
- Saleh DM, Abdelghani R. (2022). 'Clinical evaluation of autologous platelet rich plasma injection in postmenopausal vulvovaginal atrophy: a pilot study.' Journal of Cosmetic Dermatology.
- Tedesco M, et al. (2020). 'Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients.' Journal of Dermatological Treatment.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware patient information.
NICE interventional procedures guidance
NICE is a UK authority for interventional procedure governance and supports cautious language about evidence, consent and audit.
FDA safety communication on vaginal rejuvenation devices
This safety communication is a useful regulatory reference for avoiding over-claiming around sexual enhancement procedures.
RCOG patient information on menopause symptom treatment
RCOG patient information supports assessment-led discussion of vaginal dryness, discomfort and hormone-related symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 445 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers, evidence reviews; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. Disclaimer: The information provided in this document is for educational and informational purposes only and does not constitute medical advice. While Platelet-Rich Plasma (PRP) therapy has early clinical interest for treating vaginal burning, irritation, and conditions like GSM and Lichen Sclerosus, it is often used off-label. Individual results may vary. Always consult with an appropriately qualified healthcare professional or gynaecologist to obtain a proper diagnosis, discuss contraindications, and determine the safest, most appropriate treatment plan for your specific medical needs. Results vary. Not a cure.
